Status:

COMPLETED

Covid-19 Vaccine Response in Elderly Subjects

Lead Sponsor:

University Hospital, Lille

Conditions:

Covid19 Vaccine

Eligibility:

All Genders

40+ years

Brief Summary

The objective of this research is to assess the amplitude and quality of the vaccine response against SARS-CoV-2, defined here by its characteristics established at 3 months, and its persistence over ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Target population.
  • Elderly persons \> 65 years old residing in an institution for the elderly or in a long-term care unit for whom an anti-SARS-CoV-2 vaccination is indicated as recommended by French Health Authority (HAS)
  • Male or female resident in an institution for the elderly or in a long-term care unit
  • For whom consent has been obtained prior to any SARS-CoV-2 vaccination (or from the legal guardian/curator) by COMIRNATY®.
  • Having consented to participate in the study, and willing to comply with all study procedures and its duration
  • Socially insured patient
  • Control population
  • Health and medico-social sector professionals aged between 40 and 65 years old for whom a COMIRNATY® anti-SARS-CoV-2 vaccination is indicated as recommended by the HAS.
  • Male or female between 40 and 65 years of age included
  • For whom consent has been obtained prior to any COMIRNATY® SARS-CoV-2 vaccination.
  • Having consented to participate in the study, and willing to comply with all study procedures and its duration
  • Socially insured subject
  • Exclusion Criteria, for both groups :
  • Progressive infectious pathology
  • Progressive neoplastic pathology (or remission of \< 5 years)
  • Treatment with long-term corticosteroids or immunosuppressants
  • Refuse of consent to vaccination or study

Exclusion

    Key Trial Info

    Start Date :

    February 18 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    March 28 2023

    Estimated Enrollment :

    264 Patients enrolled

    Trial Details

    Trial ID

    NCT04760704

    Start Date

    February 18 2021

    End Date

    March 28 2023

    Last Update

    December 26 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    CHU lille

    Lille, France, 59037